For example, while Borroni and co-authors reported a promising ability to differentiate PSP from other neurodegenerative diseases, including CBD, using a specific tau fragment ratio [25], subsequent attempts by another research group failed to replicate these findings [27]. The gene discussed is MAPT; the disease is supranuclear palsy, progressive, 1.